Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system has become and it is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry. If the administration takes no action, Medicare recipients will continue to see their biggest premium More
The post On Medicare Limiting Coverage for Alzheimer’s Drug appeared first on CounterPunch.org.
This content originally appeared on CounterPunch.org and was authored by Sen. Bernard Sanders.
Sen. Bernard Sanders | Radio Free (2022-01-12T09:18:34+00:00) On Medicare Limiting Coverage for Alzheimer’s Drug. Retrieved from https://www.radiofree.org/2022/01/12/on-medicare-limiting-coverage-for-alzheimers-drug/
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.